Matsushita Masahide, Matsumoto Kaori, Kitamura Satoko, Komatsu Naoki, Seo Hiromi, Takeuchi Seisho
Kochi General Rehabilitation Hospital Kochi Japan.
Department of General Medicine Kochi Medical School Hospital Nankoku Japan.
J Gen Fam Med. 2020 Sep 3;22(1):24-27. doi: 10.1002/jgf2.368. eCollection 2021 Jan.
Migraine is a common headache disorder, with a 1 year prevalence rate of 6.0 %. However, less than 10% of patients with migraine receive medication in hospital. "My Headache Checker," a brief and self-administered migraine screening tool, which includes osmophobia in addition to the ID-Migraine™ three-item subset, was developed. The objective of this study was to analyze the applicability of "My Headache Checker" in Japanese patients.
A total of 238 patients visiting the outpatient department were enrolled in the study. The patients' chief complaint was not headache. "My Headache Checker" was administered to the patients. Subsequently, they were evaluated by a generalist for the diagnosis of headache. The clinical diagnosis of headache was determined based on the International Classification of Headache Disorders Ⅲ.
Twenty (8.4%) patients satisfied the criteria for the diagnosis of migraine. Sensitivity, specificity, positive predictive value, and negative predictive value of "My Headache Checker" were 0.90, 0.83, 0.69, and 0.95, respectively. Sensitivity, specificity, positive predictive value, and negative predictive value of the ID-Migraine™ were 0.90, 0.85, 0.72, and 0.95, respectively.
The majority of migraine patients are missed in busy outpatient departments. Our results suggest that "My Headache Checker" is a useful tool in diagnosing unrecognized migraine patients. However, the addition of osmophobia did not contribute to improve the screening power of the ID-Migraine™.
偏头痛是一种常见的头痛疾病，1年患病率为6.0%。然而，不到10%的偏头痛患者在医院接受药物治疗。开发了一种简短的自我管理偏头痛筛查工具“My Headache Checker”，除了ID-Migraine™三项子集外，还包括畏光症状。本研究的目的是分析“My Headache Checker”在日本患者中的适用性。
共有238名到门诊就诊的患者纳入本研究。患者的主要诉求不是头痛。对患者进行“My Headache Checker”测试。随后，由一名全科医生对他们进行头痛诊断评估。头痛的临床诊断根据《国际头痛疾病分类Ⅲ》确定。
20名（8.4%）患者符合偏头痛诊断标准。“My Headache Checker”的敏感性、特异性、阳性预测值和阴性预测值分别为0.90、0.83、0.69和0.95。ID-Migraine™的敏感性、特异性、阳性预测值和阴性预测值分别为0.90、0.85、0.72和0.95。
在繁忙的门诊中，大多数偏头痛患者被漏诊。我们的结果表明，“My Headache Checker”是诊断未被识别的偏头痛患者的有用工具。然而，增加畏光症状并没有提高ID-Migraine™的筛查能力。
